60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) kicked off on Monday, up 44.69% from the previous trading day, before settling in for the closing price of $1.12. Over the past 52 weeks, SXTP has traded in a range of $1.03-$23.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 2.28% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 62.07%. With a float of $1.29 million, this company’s outstanding shares have now reached $1.68 million.
In an organization with 3 employees, it is important to assess its efficiency.
60 Degrees Pharmaceuticals Inc (SXTP) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of 60 Degrees Pharmaceuticals Inc is 23.67%, while institutional ownership is 2.01%. The most recent insider transaction that took place on Jan 31 ’24, was worth 75,000. In this transaction Director of this company bought 200,000 shares at a rate of $0.38, taking the stock ownership to the 424,934 shares. Before that another transaction happened on Jan 31 ’24, when Company’s President and CEO bought 25,974 for $0.38, making the entire transaction worth $9,740. This insider now owns 703,599 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 62.07% per share during the next fiscal year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Take a look at 60 Degrees Pharmaceuticals Inc’s (SXTP) current performance indicators. Last quarter, stock had a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.03, a number that is poised to hit -2.82 in the next quarter and is forecasted to reach -2.76 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
Let’s dig in a bit further. During the last 5-days, its volume was 2.8 million. That was better than the volume of 0.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.27%. Additionally, its Average True Range was 0.42.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 9.52%, which indicates a significant decrease from 37.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 196.35% in the past 14 days, which was higher than the 118.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7779, while its 200-day Moving Average is $5.0304. However, in the short run, 60 Degrees Pharmaceuticals Inc’s stock first resistance to watch stands at $2.1533. Second resistance stands at $2.6867. The third major resistance level sits at $3.1733. If the price goes on to break the first support level at $1.1333, it is likely to go to the next support level at $0.6467. The third support level lies at $0.1133 if the price breaches the second support level.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
The company with the Market Capitalisation of 2.73 million has total of 12,206K Shares Outstanding. Its annual sales at the moment are 250 K in contrast with the sum of -3,770 K annual income. Company’s last quarter sales were recorded 150 K and last quarter income was 430 K.
